16434-76-7Relevant articles and documents
Novel copper(II) and zinc(II) complexes of halogenated bidentate N,O-donor Schiff base ligands: Synthesis, characterization, crystal structures, DNA binding, molecular docking, DFT and TD-DFT computational studies
Ashfaq, Muhammad,Behjatmanesh-Ardakani, Reza,Chavoshpour-Natanzi, Zahra,Kargar, Hadi,Kazemi, Zahra,Mirkhani, Valiollah,Nawaz Tahir, Muhammad,Sahraei, Atefeh,Sarvian, Asiyehalsadat,Torabi, Vajiheh
, (2020/10/08)
Eight novel complexes, including: [Cu(L1)2]: C1, [Cu(L2)2]: C2, [Cu(L3)2]: C3, [Cu(L4)2]: C4, [Zn(L1)2]: Z1, [Zn (L2)2]: Z2
Vanadyl binary schiff base complexes containing N2O2 coordination sphere: Synthesis, ab initio calculations and thermodynamic properties
Asadi, Mozaffar,Ghatee, Mohammad Hadi,Torabi, Susan,Mohammadi, Khosro,Moosavi, Fatemeh
, p. 63 - 72 (2013/07/25)
Some vanadyl complexes were synthesized by treating a methanolic solution of the appropriate Schiff base ligand and one equivalent of VO(SO 4)2 to yield [(VOL2 1-14)](L= Salicylaldehyde's derivatives, Schemes 1,
Antihyperglycemic, α-glucosidase inhibitory and DPPH free radical scavenging activity of 5-bromosalicylaldehyde and schiff bases
Misra, Sristicheta,Pandeya, Krishna Bihari,Tiwari, Ashok Kumar,Ali, Amtul Zehra,Saradamani, Thimmapatruni,Agawane, Sachin Bharat,Madhusudana, Kuncha
experimental part, p. 1431 - 1437 (2012/05/20)
α-Glucosidase inhibition and DPPH free radical scavenging by 5-bromosalicylaldehyde and some Schiff bases have been measured. 5-Bromosalicylaldehyde shows lowest IC50 value (8.80 μM) for α-glucosidase inhibition and also shows good results in in vivo experiments for antihyperglycemic potential. Springer Science+Business Media, LLC 2010.